This invention relates generally to docking devices for bioprostheses, including implantable bioprosthetic heart valves.
The unique geometry and sometimes irregular size of a patient's native heart valve anatomy present challenges to providing an implantable bioprosthetic heart valve that fits within and is provided in intimate contact or seal with the surrounding tissue.
The present disclosure generally relates to docking devices for bioprostheses, such as bioprosthetic heart valves, and, more particularly, to docking devices that include a three-dimensional (3D) woven fabric, and methods of making such docking devices.
In some implementations, the present disclosure relates to a docking device for a bioprosthesis comprising a 3D woven fabric forming a shaped element having an internal surface, an outer surface, and a thickness therebetween, and a filler structure coupled to the outer surface of the shaped element. The bioprosthesis can be a heart valve.
In certain embodiments, the 3D woven fabric comprises first, second, and third different types of fibers or yarns. For example, the first type of fiber or yarn can comprise a shape memory material, the second type of fiber or yarn can comprise a low-melt thermoplastic polymer or resin, and the third type of fiber or yarn can comprise a high-tenacity biocompatible material. In certain embodiments, the shape memory material comprises Nitinol. In certain embodiments, the low-melt thermoplastic polymer or resin has a melting point between 85 degrees Celsius and 200 degrees Celsius. For example, the low-melt thermoplastic polymer or resin can comprise Nylon. In certain embodiments, the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
The filler structure can be covered with a material having low porosity and reduced permeability. In certain embodiments, the filler structure comprises polymer foam. For example, the polymer foam can be at least partially covered with a tubular woven fabric. In certain embodiments, the tubular woven fabric comprises PET.
In some implementations, the present disclosure relates to a 3D woven fabric for a bioprosthesis docking device comprising a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material. The shape memory material can comprise Nitinol. In certain embodiments, the low-melt thermoplastic polymer or resin has a melting point of 85 degrees Celsius to 200 degrees Celsius. The low-melt thermoplastic polymer or resin can comprise Nylon. The high-tenacity biocompatible material can comprise PET.
In some implementations, the present disclosure relates to a method for making a docking device for a bioprosthesis. The method comprises weaving a 3D woven fabric by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material, and pressing and heating the 3D woven fabric over a shape-setting mold at temperatures greater than a melting point of the low-melt thermoplastic polymer or resin. In certain embodiments, the shape memory material comprises Nitinol, the low-melt thermoplastic polymer or resin comprises Nylon having a melting point of 85 degrees Celsius to 200 degrees Celsius, and the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
The method can further comprise attaching a filler structure to a surface of the 3D woven fabric. For example, attaching the filler structure can comprise sewing the filler structure to the surface of the 3D woven fabric. The method can further comprise covering the filler structure with a tubular woven fabric comprising PET, wherein the filler comprises polymer foam.
Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the inventions. In addition, various features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure. Throughout the drawings, reference numbers may be reused to indicate correspondence between reference elements.
The headings provided herein are for convenience only and do not necessarily affect the scope or meaning of the claimed invention.
Although certain preferred embodiments and examples are disclosed below, inventive subject matter extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and to modifications and equivalents thereof. Thus, the scope of the claims that may arise herefrom is not limited by any of the particular embodiments described below. For example, in any method or process disclosed herein, the acts or operations of the method or process may be performed in any suitable sequence and are not necessarily limited to any particular disclosed sequence. Various operations may be described as multiple discrete operations in turn, in a manner that may be helpful in understanding some embodiments; however, the order of description should not be construed to imply that these operations are order dependent. Additionally, the structures, systems, and/or devices described herein may be embodied as integrated components or as separate components. For purposes of comparing various embodiments, certain aspects and advantages of these embodiments are described. Not necessarily all such aspects or advantages are achieved by any particular embodiment. Thus, for example, various embodiments may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other aspects or advantages as may also be taught or suggested herein.
Overview
Certain docking devices and methods utilize a woven or knitted fabric skirt material. In some implementations, textile skirts are made by using polyethylene terephthalate (PET) in both warp and weft directions. However, generally, the PET material used may not have a shape memory effect that can change shape in connection with a trigger or stimulus, and may not be sufficiently elastic to provide for recovery after the deforming stress is removed. Therefore, it may be desirable to implement docking devices comprising fabrics and/or features that allow for improved flexibility with respect to shape or form. Some embodiments of docking devices disclosed herein are configured to adjust shape and/or form at least partially to the surrounding conditions/anatomy, and can take complex shapes to accommodate various different anatomies. In some implementations, the use of foam, polymer and/or biocompatible alloy with controlled diameter, size, and stiffness enables docking devices in accordance with the present disclosure to adjust and/or accommodate its shape or form to relatively complex anatomic geometries (e.g. different annulus sizes and/or shapes). That is, certain docking devices disclosed herein may be considered “universal” docking devices that provide desirable fit for a variety of sizes and/or shapes of patient anatomies.
Universal docking devices may be desired for use with certain implantable medical devices. For example, a universal docking device in accordance with the present disclosure may better conform to the complex anatomy associated with an implant site in some configurations. Furthermore, particularly with respect to bioprosthetic heart valves, universal docking devices in accordance with one or more embodiments of the present disclosure may help prevent paravalvular leakage and/or eliminate the need to carefully size the existing heart valves. With respect to these benefits, docking devices in accordance with one or more embodiments of the present disclosure can be configured to change shape and/or provide shape recovery after a deforming stress is removed, and can adjust to surrounding conditions to accommodate different complex anatomic geometries. Such attributes and/or characteristics can serve to at least partially mitigates paravalvular leakage.
Some embodiments disclosed herein provide a device that is configured and/or designed to improve the fit of an implantable bioprosthetic heart valve within a native valve annulus, which can advantageously at least partially mitigate issues associated with valve sizing and/or paravalvular leakage. For example, generally, the unique and/or irregular size and/or surface characteristics of native valve annuli can present challenges to providing an implantable bioprosthetic heart valve that fits within, and is provided in intimate contact or seal with, the valve annulus. To address such challenges, some embodiments disclosed herein advantageously provide a tubular or cylindrically-shaped device that is radially compressible for delivery and implantation in the native valve annulus before implantation of a bioprosthetic valve.
The structure of tubular or cylindrically-shaped devices in accordance with the present disclosure can comprise both an inner three-dimensional (3D) woven fabric and an outer covering of polymeric foam. For example, the 3D woven fabric can comprise three different fibers and/or yarns having different material properties. Different types of fibers and/or yarns that may be used can include shape memory material, such as Nitinol, low-melt thermoplastic polymer or resin having a melting point in the range of about 166-175° C., such as Nylon, and high-tenacity biocompatible material, such as PET. Furthermore, the polymeric foam can be attached to the outer surface of the 3D woven fabric and can provide a compressible seal with the native annulus.
In some implementations, docking devices in accordance with the present disclosure can be manufactured to the desired shape at least in part by pressing and/or heating the 3D woven fabric over a shape-setting mold at temperatures above the melting point of the low-melt thermoplastic polymer or resin. The melting of low-melt material can function as an adhesive to set the shape of the fabric. After the desired shape of the 3D woven fabric is set, a foam material can be attached or sewed onto the 3-D woven fabric.
In some implementations, the present disclosure provides a method for fabricating a universal docking device, wherein a main body of the docking device is made of shape memory material (e.g., Ni—Ti alloy, Nitinol) and thermoplastic fibers by utilizing 3D weaving techniques. Such 3D weaving techniques may be implemented on a specialized 3D weaving machine. For example, in some 3D weaving implementations in accordance with embodiments of the present disclosure, three sets of yarns are used to interlace with each other, as compared to two sets of yarn in flat-woven structures. The weave can be orthogonal or multilayer, and multiple layers can be woven together to form a 3D fabric. In the width-wise (i.e., “filling” or “weft”) direction, memory metal (e.g., Ni—Ti) round wire and low-melt Nylon can be used apart from high tenacity polyethylene terephthalate (PET). The melting temperature of the low-melt nylon resin can be designed to be in range of 166-175° C.
After weaving the fabric, methods of fabricating a docking device in accordance with one or more embodiments of the present disclosure can involve pressing the fabric over a shape-setting mold (e.g., having a specific custom shape) and heated for a period of time (e.g., 30-60 min) at temperatures higher than the melting point of the low-melt Nylon resin, thereby causing the low-melt nylon to melt. The melted Nylon can act as an adhesive, and can at least partially set the shape of the fabric. The method may further involve leaving the shape-set fabric on the mold to cool-off for a period of time (e.g., 1 hour), and then removing the shape-set fabric and covering the same with a tubular woven fabric filled with foam or other at least partially compressible material (e.g., polymer, biocompatible alloy, etc.). The use of foam, polymer or biocompatible alloy outside the device can advantageously help reduce paravalvular leakage as such material can be compressed during delivery to the annulus, and once deployment is complete, the material can at least partially decompress and form an improved seal. The use of tubular textile around the form or other compressible material can help control the porosity of such materials, as foam or polymeric materials can be undesirably porous; the outside textile (e.g., PET) covering can reduce permeability.
Universal Docking Device
With reference now to
The 3D woven fabric 10 can be a hybrid fabric comprising polyethylene terephthalate (PET), memory metal (e.g., Ni—Ti alloy, Nitinol), and low-melt Nylon alloy, and can be made using any suitable or desirable weaving technique or configuration/arrangement. For example, in the width-wise (i.e., “weft,” “filling”) direction, memory metal (e.g., Ni—Ti) round wire and low-melt Nylon can be used apart from high-tenacity PET, or the memory metal wire can be used entirely the weft/filling direction in order to increase the shape memory effect of the fabric. The woven fabric structure 10 can be woven in 2D, 3D, and can be configured to fit any anatomical structure, by using the shape memory effect, or super elastic effect, of the memory metal wire or other material of the fabric. The woven fabric 10 can be configured to fit any desirable human anatomical part(s) through the use of shape memory alloy to change the shape of the mold. The fabric 10 can also be used in sheet form as a scaffold for tissue engineering with shape memory effect customized to any human anatomical shape.
In use, the docking device 100 can be compressed and delivered, such as through a catheter, to the implantation site. At the implantation site, the docking device 100 can be expanded to fit, and be held at, the local anatomy (e.g., the native heart valve annulus) associated with the implantation site. The docking device 100 can then act as a landing site for a bioprosthesis 200, such as a transcatheter heart valve.
The docking device 100 can be configured or designed to be implanted at any suitable or desirable implantation site. However, implantation sites of different patients can present relative irregularity of shapes across patients. By using shape memory effect for the fabric 10, the docking device 100 can be used to fit into irregular shapes. The device 100 can be configured to be compressed and delivered through a catheter to the implant site. At the delivery site, depending on whether using super-elastic shape memory metal or polymer is used, the device 100 can expand by itself or through temperature stimulus to fit the size of the implantation site anatomy (e.g., heart valve annulus). Foam or other compressible material (not shown in
In use, the filler structure 40 can be configured to be compressed during delivery of the docking device 100 to the implantation site (e.g., valve annulus). Once deployed, the filler 40 can be configured to decompress to provide a compressible seal against the surrounding native tissue. This compressible seal can be optimized by varying the shape, size, and stiffness of the filler 40. For example, the filler 40 can be configured, as shown in
In some embodiments, the filler 40 can be dimensioned to cover at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or 100% of the outer surface 35 of the hollow cylinder 30. In some embodiments, the filler can also be dimensioned to cover a percentage of the outer surface that includes and is between any two of the foregoing values.
3D Woven Fabric
In some implementations, the present disclosure is related to relatively complex textile structures generated by utilizing weaving, braiding, knitting and/or a combination thereof. Such textiles structures can be generated using shape memory fibers or alloys (e.g., Nitinol) in combination with one or more thermoplastic textile fibers, such as Nylon, polyethylene terephthalate (PET), polypropylene (PP), and/or polybutylene terephthalate (PBT). Hybrid textile structures in accordance with the present disclosure can be created using a base substrate fabric, and using electro-spinning to lay shape memory fibers on top of the substrate fabric, or by wrapping a low-melt Nylon in a core-sheath structure. As described above, the textile structure can be formed into a hollow cylinder form, wherein the outside of the cylinder form is at least partially enveloped by foam, polymer (e.g. medical-grade silicone), and/or a biocompatible alloy.
Devices in accordance with some implementations can include a three-dimensional (3D) woven fabric that is formed into a hollow cylinder, as well as a polymer foam attached to the hollow cylinder. The 3D woven fabric can advantageously comprise three different types of yarns or fibers, as described in detail herein. For example, the 3D woven fabric can comprise one or more of the following types of yarns and/or fibers: shape memory material, low-melt thermoplastic polymer or resin, and high-tenacity biocompatible material.
Example embodiments of 3D woven fabrics for use with docking devices are described below. As described above, 3D woven fabrics in accordance with embodiments of the present disclosure can comprise three different types of fibers or yarns. In some embodiments, the three different types of fibers or yarns can comprise a combination of a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material. In some embodiments, the shape memory material can be or comprise a metal alloy. The metal alloy can comprise nickel and/or titanium, such as Nitinol. In one embodiment, the shape memory material can provide the desired shape and geometry of the device.
With respect to the low-melt thermoplastic polymer or resin material, in some embodiments, such material can act as a binder or glue to fuse woven layers of the 3D fabric 10 together and conform the 3D woven fabric 10 to a desired shape. In some embodiments, the low-melt thermoplastic polymer or resin can be or comprise Nylon, for example.
The low-melt thermoplastic polymer or resin can have a relatively low-melting point. In accordance with an optional aspect, the low-melting point of the low-melt thermoplastic polymer or resin can be 200° C. or less, 195° C. or less, 190° C. or less, 185° C. or less, 180° C. or less, 175° C. or less, 170° C. or less, 165° C. or less, 160° C. or less, 155° C. or less, 150° C. or less, 145° C. or less, 140° C. or less, 135° C. or less, 130° C. or less, 125° C. or less, 120° C. or less, 115° C. or less, 110° C. or less, 105° C. or less, and 100° C. or less. The low-melting point can be within a range that includes and is between any two of the foregoing values.
With respect to the high-tenacity biocompatible material, such material can improve the durability of the 3D woven fabric 10 and promote tissue growth. In some embodiments, the high-tenacity biocompatible material can have a tenacity, or breaking load, of about 5 grams per Denier or more, about 6 grams per Denier or more, about 7 grams per Denier or more, about 8 grams per Denier or more, about 9 grams per Denier or more, about 10 grams per Denier or more, about 11 grams per Denier or more, about 12 grams per Denier or more, about 13 grams per Denier or more, about 14 grams per Denier or more, or about 15 grams per Denier. The breaking load can also be within a range that includes and/or is between any two of the foregoing values. In some embodiments, the high-tenacity biocompatible material can be PET.
In another embodiment, methods for making a docking device 100 for a bioprosthesis 200 are described. One such method comprises weaving a 3D woven fabric 10 by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material. The shape memory material can be a metal alloy. The metal alloy can comprise nickel and titanium, such as Nitinol. The low-melt thermoplastic polymer or resin can be a polymer having a low-melting point. The polymer can be nylon. The high-tenacity biocompatible material can be PET.
3D woven fabrics can generally be woven by manipulating yarns in the length (“warp,” or “ends”), width (“weft,” “filling,” or “picks”), and through-the-thickness directions. In some embodiments, the combination of the low-melt thermoplastic polymer and the 3D weave pattern can allow the thickness of the 3D woven fabric to be varied based on the number of layers of the weft and warp yarns. Thus, in one aspect, the thickness of the 3D woven fabric can be increased by increasing the number of layers of the weft and warp yarns with the low-melt thermoplastic polymer and the through-the-thickness yarns binding the plurality of layers together.
The through-the-thickness yarn can be incorporated at varying levels and angles within orthogonal (
With reference to
In some embodiments, the 3D woven fabric 10 can comprise an orthogonal weave structure, wherein the set of warp yarns 15 can comprise a shape memory material, the set of filling yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of through-the-thickness yarns 25 can comprise a high-tenacity biocompatible material.
In some embodiments, the 3D woven fabric 10 can comprise an orthogonal weave structure, wherein the set of warp yarns 15 can comprise a high-tenacity biocompatible material, the set of filling yarns 20 can comprise a shape memory material, and the set of through-the-thickness yarns 25 can comprise a low-melt thermoplastic polymer or resin.
With reference to
In some embodiments, the 3D woven fabric 10 can comprise a multilayer weave structure, wherein the set of warp yarns 15 can comprise a shape memory material, the set of weft yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of binding yarns 25 can comprise a high-tenacity biocompatible material.
In some embodiments, the 3D woven fabric 10 can comprise a multilayer weave structure, wherein the set of warp yarns 15 can comprise a high-tenacity biocompatible material, the set of weft yarns 20 can comprise a shape memory material, and the set of binding yarns 25 can comprise a low-melt thermoplastic polymer or resin.
With reference to
In some embodiments, the 3D woven fabric 10 can comprise an angle-interlock structure, wherein the set of warp yarns 15 can comprise a shape memory material, the set of straight weft yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of bias weft yarns 25 can comprise a high-tenacity biocompatible material.
In some embodiments, the 3D woven fabric 10 can comprise an angle-interlock structure, wherein the set of warp yarns 15 can comprise a high-tenacity biocompatible material, the set of straight weft yarns 20 can comprise a shape memory material, and the set of bias weft yarns 25 can comprise a low-melt thermoplastic polymer or resin.
It should be understood that other varieties of 3D weave structures, including different varieties of orthogonal, multilayer, and angle-interlock weave structures, may be used in connection with embodiments of the present disclosure. To optimize the physical characteristics of the docking device 100 for use with a particular bioprosthesis 200 or installation site, the 3D woven fabric 10 can be manufactured using any of the different varieties of 3D weave structures.
For example, in use with a bioprosthetic heart valve, the docking device 100 may be subjected to compressive forces between the bioprosthesis 200 and the surrounding native valve tissue. The compressibility of the docking device 100 can be, in part, a function of the compressibility of the 3D woven fabric, which can, in turn, be a function of the fabric's weave structure, fabric density, and/or other characteristics of the constituent fibers/yarns. Accordingly, the 3D woven fabric's 10 weave structure and fabric density can be selected to optimize the compressibility of docking device 100.
Fabric density can be quantified by ends-per-inch (EPI) and/or picks-per-inch (PPI). In some embodiments, the 3D woven fabric 10 can have about 115 EPI, about 120 EPI, about 125 EPI, about 130 EPI, about 135 EPI, about 140 EPI, about 145 EPI, about 150 EPI, about 155 EPI, about 160 EPI, about 165 EPI, about 170 EPI, about 175 EPI, about 180 EPI, about 185 EPI, about 190 EPI, about 195 EPI, about 200 EPI, about 205 EPI, about 210 EPI, about 215 EPI, about 220 EPI, about 225 EPI, about 230 EPI, about 235 EPI, about 240 EPI, about 245 EPI, about 250 EPI, about 255 EPI, about 260 EPI, about 265 EPI, about 270 EPI, about 275 EPI, about 280 EPI, about 285 EPI, about 290 EPI, about 295 EPI, about 300 EPI, about 305 EPI, about 310 EPI, about 315 EPI, about 320 EPI, about 325 EPI, about 330 EPI, about 335 EPI, about 340 EPI, about 345 EPI, or about 350 EPI. In some embodiments, the 3D woven fabric 10 can have ends-per-inch between and including any two of the foregoing values.
In one embodiment, the 3D woven fabric 10 can have about 115 PPI, about 120 PPI, about 125 PPI, about 130 PPI, about 135 PPI, about 140 PPI, about 145 PPI, about 150 PPI, about 155 PPI, about 160 PPI, about 165 PPI, about 170 PPI, about 175 PPI, about 180 PPI, about 185 PPI, about 190 PPI, about 195 PPI, about 200 PPI, about 205 PPI, about 210 PPI, about 215 PPI, about 220 PPI, about 225 PPI, about 230 PPI, about 235 PPI, about 240 PPI, about 245 PPI, about 250 PPI, about 255 PPI, about 260 PPI, about 265 PPI, about 270 PPI, about 275 PPI, about 280 PPI, about 285 PPI, about 290 PPI, about 295 PPI, about 300 PPI, about 305 PPI, about 310 PPI, or about 315 PPI, about 320 PPI, about 325 PPI, about 330 PPI, about 335 PPI, about 340 PPI, about 345 PPI, or about 350 PPI. In some embodiments, the 3D woven fabric 10 can have picks-per-inch between and including any two of the foregoing values.
In some embodiments, the docking device 100 exhibits a compressibility of no more than 5%, no more than 10%, no more than 15%, no more than 20%, no more than 25%, no more than 30%, no more than 35%, no more than 40%, no more than 45%, no more than 50%, no more than 55%, no more than 60%, no more than 65%, or no more than 70% across its thickness. In some embodiments, the docking device can exhibit a compressibility of between and including any two of the foregoing values.
With reference to
In some embodiments, the method can further comprise the step of attaching a filler 40 to a surface 35 of the 3D woven fabric 10, for example by sewing the filler 40 to the surface 35 of the 3D woven fabric 10. In a further embodiment, the method can include the step of covering the filler 40 with a tubular woven fabric 45 comprising, for example, polyethylene terephthalate (PET). In some embodiments, the filler 40 can be a polymer foam.
It should be appreciated from the foregoing description that the present invention provides a universal docking device that can be radially compressible, for delivery and implantation, and that changes shape and recovers after a deforming stress is removed. The docking device adjusts to surrounding conditions to accommodate different complex anatomic geometries, and provides conforming support while minimizing or eliminating leakage around the implanted device.
The invention has been described in detail with reference only to the presently preferred embodiments. Persons skilled in the art will appreciate that various modifications can be made without departing from the invention. Accordingly, the invention is defined only by the following claims.
Depending on the embodiment, certain acts, events, or functions of any of the processes described herein can be performed in a different sequence, may be added, merged, or left out altogether. Thus, in some embodiments, not all described acts or events are necessary for the practice of the processes. Moreover, in some embodiments, acts or events may be performed concurrently.
Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is intended in its ordinary sense and is generally intended to convey that some embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous, are used in their ordinary sense, and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Conjunctive language such as the phrase “at least one of X, Y and Z,” unless specifically stated otherwise, is understood with the context as used in general to convey that an item, term, element, etc. may be either X, Y or Z. Thus, such conjunctive language is not generally intended to imply that some embodiments require at least one of X, at least one of Y and at least one of Z to each be present.
It should be appreciated that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, Figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of one or more of the various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Moreover, any components, features, or steps illustrated and/or described in a particular embodiment herein can be applied to or used with any other embodiment(s). Further, no component, feature, step, or group of components, features, or steps are necessary or indispensable for each embodiment. Thus, it is intended that the scope of the inventions herein disclosed and claimed below should not be limited by the particular embodiments described above, but should be determined only by a fair reading of the claims that follow.
This application is a continuation of U.S. patent application Ser. No. 15/841,046, filed on Dec. 13, 2017 and entitled DOCKING DEVICE MADE WITH 3D WOVEN FABRIC, now U.S. Pat. No. 10,813,749, which claims priority to U.S. Provisional Application No. 62/436,866, filed on Dec. 20, 2016 and entitled DOCKING DEVICE MADE WITH 3D WOVEN FABRIC, the disclosures of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
1392535 | Stevenson | Oct 1921 | A |
3365728 | Edwards et al. | Jan 1968 | A |
3725961 | Magovern et al. | Apr 1973 | A |
3983581 | Angell et al. | Oct 1976 | A |
4035849 | Angell et al. | Jul 1977 | A |
4182618 | Tschudy | Jan 1980 | A |
4187618 | Diehl | Feb 1980 | A |
5059177 | Towne et al. | Oct 1991 | A |
5258023 | Reger | Nov 1993 | A |
5399418 | Hartmanns | Mar 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5476506 | Lunn | Dec 1995 | A |
5554185 | Block et al. | Sep 1996 | A |
5628786 | Banas et al. | May 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5711960 | Shikinami | Jan 1998 | A |
5755783 | Stobie et al. | May 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5776188 | Shepherd et al. | Jul 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5843179 | Vanney et al. | Dec 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6110198 | Fogarty et al. | Aug 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6206911 | Milo | Mar 2001 | B1 |
6306164 | Kujawski | Oct 2001 | B1 |
6352554 | De Paulis | Mar 2002 | B2 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6432134 | Anson et al. | Aug 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6527979 | Constantz et al. | Mar 2003 | B2 |
6540782 | Snyders | Apr 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6663667 | Dehdashtian et al. | Dec 2003 | B2 |
6689162 | Thompson | Feb 2004 | B1 |
6729356 | Baker et al. | May 2004 | B1 |
6730121 | Ortiz et al. | May 2004 | B2 |
6773456 | Gordon et al. | Aug 2004 | B1 |
6797002 | Spence et al. | Sep 2004 | B2 |
6814754 | Greenhalgh | Nov 2004 | B2 |
6846325 | Liddicoat | Jan 2005 | B2 |
6904909 | Andreas et al. | Jun 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6911040 | Johnson et al. | Jun 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7077861 | Spence | Jul 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7147663 | Berg et al. | Dec 2006 | B1 |
7175652 | Cook et al. | Feb 2007 | B2 |
7192441 | Sherry | Mar 2007 | B2 |
7264632 | Wright et al. | Sep 2007 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7731742 | Schlick et al. | Jun 2010 | B2 |
7737060 | Strickler et al. | Jun 2010 | B2 |
7780725 | Haug et al. | Aug 2010 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7951195 | Antonsson et al. | May 2011 | B2 |
8105377 | Liddicoat | Jan 2012 | B2 |
8128681 | Shoemaker et al. | Mar 2012 | B2 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8377115 | Thompson | Feb 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8425593 | Braido et al. | Apr 2013 | B2 |
8430925 | Forster et al. | Apr 2013 | B2 |
8449605 | Lichtenstein et al. | May 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8657872 | Seguin | Feb 2014 | B2 |
8663322 | Keranen | Mar 2014 | B2 |
8672998 | Lichtenstein et al. | Mar 2014 | B2 |
8721717 | Shoemaker et al. | May 2014 | B2 |
8734507 | Keranen | May 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8808356 | Braido et al. | Aug 2014 | B2 |
8845721 | Braido et al. | Sep 2014 | B2 |
8940041 | Carlson et al. | Jan 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8992608 | Haug et al. | Mar 2015 | B2 |
9078747 | Conklin | Jul 2015 | B2 |
9095434 | Rowe | Aug 2015 | B2 |
9119718 | Keranen | Sep 2015 | B2 |
9220594 | Braido et al. | Dec 2015 | B2 |
9237886 | Seguin et al. | Jan 2016 | B2 |
9241794 | Braido et al. | Jan 2016 | B2 |
9289296 | Braido et al. | Mar 2016 | B2 |
9326856 | Schraut et al. | May 2016 | B2 |
9345571 | Braido et al. | May 2016 | B1 |
9351828 | Braido et al. | May 2016 | B2 |
9351831 | Braido et al. | May 2016 | B2 |
9351832 | Braido et al. | May 2016 | B2 |
9364326 | Yaron | Jun 2016 | B2 |
9414911 | Braido et al. | Aug 2016 | B2 |
9463268 | Spence | Oct 2016 | B2 |
9474599 | Keranen | Oct 2016 | B2 |
9545307 | Braido et al. | Jan 2017 | B2 |
9549815 | Braido et al. | Jan 2017 | B2 |
9622863 | Karapetian et al. | Apr 2017 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010027338 | Greenberg | Oct 2001 | A1 |
20010039450 | Pavcnik et al. | Nov 2001 | A1 |
20030074058 | Sherry | Apr 2003 | A1 |
20030225420 | Wardle | Dec 2003 | A1 |
20030236567 | Elliot | Dec 2003 | A1 |
20040033364 | Spiridigliozzi et al. | Feb 2004 | A1 |
20040082989 | Cook et al. | Apr 2004 | A1 |
20040098096 | Eton | May 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040215320 | Machek | Oct 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050119735 | Spence et al. | Jun 2005 | A1 |
20050137687 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060089672 | Martinek | Apr 2006 | A1 |
20070073387 | Forster et al. | Mar 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20070293927 | Frank et al. | Dec 2007 | A1 |
20080033542 | Antonsson et al. | Feb 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080208330 | Keranen | Aug 2008 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090132035 | Roth et al. | May 2009 | A1 |
20100145440 | Keranen | Jun 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20100318184 | Spence | Dec 2010 | A1 |
20120035719 | Forster et al. | Feb 2012 | A1 |
20120059458 | Buchbinder et al. | Mar 2012 | A1 |
20120116492 | Seibold et al. | May 2012 | A1 |
20120215303 | Quadri et al. | Aug 2012 | A1 |
20130006279 | Mortarino | Jan 2013 | A1 |
20130273795 | Richter | Oct 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20130338765 | Braido et al. | Dec 2013 | A1 |
20140074299 | Endou et al. | Mar 2014 | A1 |
20140172070 | Seguin | Jun 2014 | A1 |
20140243966 | Garde et al. | Aug 2014 | A1 |
20140277424 | Oslund | Sep 2014 | A1 |
20140303719 | Cox et al. | Oct 2014 | A1 |
20140350663 | Braido et al. | Nov 2014 | A1 |
20140379074 | Spence et al. | Dec 2014 | A1 |
20150073541 | Salahieh et al. | Mar 2015 | A1 |
20150073546 | Braido | Mar 2015 | A1 |
20150127088 | Carlson et al. | May 2015 | A1 |
20150157455 | Hoang et al. | Jun 2015 | A1 |
20150190552 | Richter | Jul 2015 | A1 |
20150230921 | Chau et al. | Aug 2015 | A1 |
20150230953 | Bar et al. | Aug 2015 | A1 |
20150282931 | Brunnett et al. | Oct 2015 | A1 |
20150282932 | Neuman et al. | Oct 2015 | A1 |
20150327999 | Board et al. | Nov 2015 | A1 |
20150335428 | Keranen | Nov 2015 | A1 |
20150374493 | Yaron et al. | Dec 2015 | A1 |
20160074165 | Spence et al. | Mar 2016 | A1 |
20160095705 | Keranen et al. | Apr 2016 | A1 |
20160184095 | Spence et al. | Jun 2016 | A1 |
20160199177 | Spence et al. | Jul 2016 | A1 |
20160213466 | Braido et al. | Jul 2016 | A1 |
20160213468 | Braido et al. | Jul 2016 | A1 |
20160242904 | Braido et al. | Aug 2016 | A1 |
20160256276 | Yaron | Sep 2016 | A1 |
20170007399 | Keranen | Jan 2017 | A1 |
20170007402 | Zerkowski et al. | Jan 2017 | A1 |
20170172736 | Chadha | Jun 2017 | A1 |
20190226126 | Hozumi | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
2002212418 | Mar 2006 | AU |
1182813 | May 1998 | CN |
104786564 | Jul 2015 | CN |
19532846 | Mar 1997 | DE |
19907646 | Aug 2000 | DE |
0592410 | Oct 1995 | EP |
0850607 | Jul 1998 | EP |
1432369 | Jun 2004 | EP |
1521550 | Apr 2005 | EP |
2155114 | Feb 2010 | EP |
1827314 | Dec 2010 | EP |
2299938 | Mar 2011 | EP |
2620125 | Jul 2013 | EP |
2572676 | Aug 2013 | EP |
2572675 | Sep 2013 | EP |
2698129 | Feb 2014 | EP |
2726018 | May 2014 | EP |
2745805 | Jun 2014 | EP |
2749254 | Jul 2014 | EP |
2806829 | Dec 2014 | EP |
2815723 | Dec 2014 | EP |
2815725 | Dec 2014 | EP |
2967851 | Jan 2016 | EP |
2926766 | Feb 2016 | EP |
2815724 | Jun 2016 | EP |
3028670 | Jun 2016 | EP |
3028671 | Jun 2016 | EP |
3025680 | Feb 2017 | EP |
3025681 | Feb 2017 | EP |
9117720 | Nov 1991 | WO |
9829057 | Jul 1998 | WO |
9748350 | Jun 1999 | WO |
0044313 | Aug 2000 | WO |
0106959 | Feb 2001 | WO |
0149213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
0219951 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0247575 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
03037222 | Oct 2003 | WO |
03088873 | Oct 2003 | WO |
03096932 | Nov 2003 | WO |
03003949 | Jan 2004 | WO |
2005084595 | Sep 2005 | WO |
2006005015 | Jan 2006 | WO |
2006011127 | Feb 2006 | WO |
2005102015 | Apr 2007 | WO |
2007067942 | Jun 2007 | WO |
2009042196 | Apr 2009 | WO |
2010121076 | Oct 2010 | WO |
2013033791 | Mar 2013 | WO |
2013110722 | Aug 2013 | WO |
2013114214 | Aug 2013 | WO |
2015023579 | Feb 2015 | WO |
2015023862 | Feb 2015 | WO |
2015127264 | Aug 2015 | WO |
2015198125 | Dec 2015 | WO |
2016038017 | Mar 2016 | WO |
2016040881 | Mar 2016 | WO |
2016130820 | Aug 2016 | WO |
Number | Date | Country | |
---|---|---|---|
20210022852 A1 | Jan 2021 | US |
Number | Date | Country | |
---|---|---|---|
62436866 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15841046 | Dec 2017 | US |
Child | 17071641 | US |